Wellframe Competitors

Altruista Health provides a suite of technology solutions that support collaborative, data-driven and person-centered approaches to population health management. Founded in 2007, Altruista Health has been recognized by Becker's Healthcare as a Top Population Health Company to Know. Today, our solutions remove barriers to care, reduce avoidable healthcare expenses and improve health outcomes for millions of Americans. Our GuidingCare platform is a web-based population health management system that enables health plans to maximize the value of their data and improve the quality of care for high-risk members. GuidingCare integrates data from a variety of systems, including medical and pharmacy claims, EMR/EHR, eligibility, HIEs and others, to power role-optimized workflow management tools for care coordination, quality improvement, care transitions management, utilization management, LTC/long term support services and more. For more information, contact us to schedule a demo at hello@altruistahealth.com.

NeuroFlow helps risk-bearing healthcare organizations improve outcomes and cost of care in complex populations by surfacing and supporting behavioral health needs that typically go undetected and under-addressed. Across payors, providers, and the federal government, NeuroFlow’s scalable technology and analytics capabilities empower organizations with actionable intelligence from real-time data collection and risk stratification, enabling them to manage populations in a financially sustainable way. Powered by deep expertise in whole-person care, NeuroFlow offers a path to risk predictability and proactive care that helps overcome the systemic challenges in today’s healthcare ecosystem.

Meet Welldoc: Flexible, clinically-validated AI tech offering personalized, predictive solutions built for today’s healthcare realities. The Welldoc platform transforms fragmented cardiometabolic data into actionable insights, connecting members, care teams, and partners with clinically rigorous and validated AI.